Adsorption of procarbazine anti-cancer Drug on the Surface of graphene: A DFT Study

Farhang Rik, Behnam; Ranjineh Khojasteh, Roya; Ahmadi, Roya

doi:10.22034/ijnc.2021.533255.1167

Document Type : Research Paper

Authors

¹ Department of Inorganic Chemistry, Faculty of Chemistry, Tehran North Branch, Islamic Azad University, Tehran, Iran

² Department of Chemistry, College of Basic Sciences, Yadegar-e-Imam Khomeini (RAH) Shahre Rey Branch, Islamic Azad University, Tehran, Iran

https://doi.org/10.22034/ijnc.2021.533255.1167

Abstract

The present study aimed to assess the adsorption of graphene with anticancer drug procarbazine in a gas and solvent phase (water) at the B3LYP/6-31G (d) theoretical level. Initially, the structures of procarbazine and graphene complexes were optimized in three configurations. Afterwards, IR calculations and molecular orbital analysis were performed. In addition, some important parameters were assessed, including the adsorption energy, Gibbs free energy changes (ΔGad), enthalpy (ΔHad) variations, thermodynamic equilibrium constant, specific heat capacity, chemical hardness, energy gap, and electrophilicity. According to the results, Gibbs free energy changes (ΔGad), enthalpy (ΔHad) variations, I-Isomer and II-Isomer and III-Isomer were negatives at various temperatures, throughout the temperature range of 298.15-310.15 K. Since according to the obtained results for adsorption of procarbazine on the graphene in I-Isomer and II-Isomer and III-Isomer were spontaneous at various temperatures, throughout the temperature range of 298.15-310.15 K. Structural properties calculated, including the density and length of C-N bonds, and the findings of the analysis of molecular orbitals indicated that the reactivity, electrophilicity, and conductivity of procarbazine are reduced after this reaction. Also the calculated specific heat capacity values indicated that graphene could be utilized as a sensing material in the construction of thermal biosensors for procarbazine determination.

Keywords

Main Subjects

Computational Chemistry

References

[1] F. Krika, A. Krika, A. Azizi, Chem. Rev. Let. 2, 59 (2019).

[2] S. Samadi, R. Ahmadi, M. Kohi, Int. J. New. Chem. 2, 8 (2015).

[3] M. Nabati, E. Pournamdari, V. Bodaghi-Namileh, Y. Dashti-Rahmatabadi, S. Sarshar, Adv. J. Chem. B 2, 64 (2020).

[4] M. Nabati, V. Bodaghi-Namileh, J. Phys. Theor. Chem. IAU Iran 15, 159 (2018).

[5] M. Nabati, V. Bodaghi-Namileh, Adv. J. Chem. A 3, 58 (2020).

[6] M. Nabati, H. Sabahnoo, E. Lohrasbi, M. Mazidi, Chem. Methodol. 3, 383 (2019).

[7] M. Mozafarjalali, M. Hajiani, A. Haji, Int. J. New. Chem. 7, 111 (2020).

[8] F. Z. Benhachem, T. Attar, F. Bouabdallah, Chem. Rev. Let. 2, 33 (2019).

[9] M. Rossetti, S. Ranallo, A. Idili, G. Palleschi, A. Porchetta, F. Ricci, Chem. Sci. 8, 914 (2017).

[10] S. Sakurai, D. Sawada, T. Yonetani, A. Tsuneshige, Biophys. J. 110, 48a (2016).

[11] B. Jensen, A. Fago, J. Inorg. Biochem. 182, 133 (2018).

[12] E. Hegin, J. Shalini, A. Subramaniyan, Int. J. New. Chem. 5, 181 (2018).

[13] Z. Sarikhani, M. Manoochehri, Int. J. New. Chem. 7, 30 (2020).

[14] M. S. Nagar, Int. J. New. Chem. 7, 150 (2020).

[15] W. A. Eaton, E. R. Henry, J. Hofrichter, S. Bettati, C. Viappiani, A. Mozzarelli, IUBMB life 59, 586 (2007).

[16] Y. Morita, T. Yamada, M. Kureishi, K. Kihira, T. Komatsu, J. Phys. Chem. B 122, 12031 (2018).

[17] M. Bender, GeneReviews, 2017, 1993 (2017).

[18] I. Benenson, S. Porter, Orthop. Nurs. 37, 221 (2018).

[19] A. Habara, M. H. Steinberg, Exp. Biol. Med. 241, 689 (2016).

[20] A. Bellelli, M. Brunori, Biochim. Biophys. Acta 1807, 1262 (2011).

[21] S. K. Tossea, E. G. Adji, B. Coulibaly, B. A. Ako, D. N. Coulibaly, P. Joly, S.-B. Assi, A. Toure, R. Jambou, BMC Res. notes 11, 215 (2018).

[22] B. J. Kumar, A. B. Kumar, L. L. Reddy, World J. Parm. Res. 5, 328 (2016).

[23] a) E. Depetris‐Chauvin, D. N. Weil, Econ. J. 128, 1207 (2017); b) S. D. Grosse, I. Odame, H. K. Atrash, D. D. Amendah, F. B. Piel, T. N. Williams, Am. J. Prev. Med. 41, S398 (2011).

[24] R. E. Ware, M. de Montalembert, L. Tshilolo, M. R. Abboud, The Lancet 390, 311 (2017).

[25] M. Nabati, V. Bodaghi-Namileh, Int. J. New. Chem. 6, 254 (2019).

[26] B. Metcalf, C. Chuang, K. Dufu, M. P. Patel, A. Silva-Garcia, C. Johnson, Q. Lu, J. R. Partridge, L. Patskovska, Y. Patskovsky, ACS Med. Chem. Lett. 8, 321 (2017).

[27] N. M. Elmaki, I. A. Al Sadawi, A. M. Gbaj, A. Hermann, Drug. Des. Intellect. Prop. Int. J. 2, 191 (2018).

[28] R. Macdonald, M. Phillips, D. Cascio, M. Collazo, R. T. Clubb, The FASEB Journal 32, 613 (2018).

[29] R. Ramachandran, C. Zhao, D. Luo, K. Wang, F. Wang, Appl. Surf. Sci. 460, 33 (2018).

[30] J.-K. Hong, E. H. Jho, H. S. Choi, G. Kang, Sci. Total Environ. 627, 1174 (2018).

[31] J. J. Yan, T. Kroll, M. L. Baker, S. A. Wilson, R. Decréau, M. Lundberg, D. Sokaras, P. Glatzel, B. Hedman, K. O. Hodgson, Proc. Natl. Acad. Sci. 116, 2854 (2019).

[32] M. Khoshouei, R. Danev, J. M. Plitzko, W. Baumeister, J. Mol. Biol. 429, 2611 (2017).

International Journal of New Chemistry

Adsorption of procarbazine anti-cancer Drug on the Surface of graphene: A DFT Study

References

References

Volume 8, Issue 4
October 2021
Pages 485-497

Adsorption of procarbazine anti-cancer Drug on the Surface of graphene: A DFT Study

References

References

Volume 8, Issue 4October 2021Pages 485-497

Volume 8, Issue 4
October 2021
Pages 485-497